Correlation Between Madrigal Pharmaceuticals and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Fate Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Fate Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Fate Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Madrigal and Fate is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Fate Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 8.56 times less return on investment than Fate Therapeutics. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 2.32 times less risky than Fate Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Fate Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 243.00 in Fate Therapeutics on September 2, 2024 and sell it today you would earn a total of 74.00 from holding Fate Therapeutics or generate 30.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Fate Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Fate Therapeutics |
Madrigal Pharmaceuticals and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Fate Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world |